PENTENYL GLYCOSIDES--TRANSFORMATIONS AT ANOMERIC CENTER
戊烯基糖苷——异头中心的转化
基本信息
- 批准号:2546017
- 负责人:
- 金额:$ 16.02万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1996
- 资助国家:美国
- 起止时间:1996-09-30 至 1999-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION: The principal investigator states that the importance of the
project stems from the fact that of the three major families of biopolymers,
proteins, oligonucleotides and oligosaccharides, the last is the least well
understood because their isolation, structure-proof, and (above all) their
laboratory syntheses have been far more difficult and demanding than in the
case of the other two. He notes that however, great strides have been made
in the techniques of isolation and structure-proof which has made many of
these oligosaccharides available intact, and it is now clear that their
structures are usually of daunting complexity. He further indicates that
with the other two biopolymers, proteins and oligonucleotides, clarification
of their biological regulatory roles accelerated markedly with the advent of
synthetic methods that made them and/or their analogs, readily available for
structure activity correlations. It is noted that oligosaccharides usually
being the primary recognition agents on cell surfaces is now widely
appreciated, this step being a prelude to subsequent critical events such as
enzymolysis, cell penetration, etc and that thus bacteria, viruses, (many)
hormones, other cells, etc. must engage in this first step, and hence
undesirable events (such as bacterial infection) can conceivably be
prevented by the use of mimics to negate the recognition step. It is
further noted that on the other hand, beneficial interactions, as in the
case of hormones, can be facilitated so as to enhance recognition.
The principal investigator states that these visionary health-related
benefits rely ultimately on ready access to synthetic oligosaccharides, or
fragments and modifications thereof for biochemical evaluation and
structure-activity investigations. He notes that since their discovery in
his laboratory six years ago, n-pentenyl glycosides have proved to be
versatile synthetic precursors for several oligosaccharides and
glycoproteins and that with their credibility thereby established, he
envisages greatly extending their synthetic potential to address problems
associated with major health hazards. It is stated that examples of these
include the lipopolysaccharides associated with Leishmaniasis and the
endotoxin from lipid A and that exploratory studies aimed at developing
methodology for these targets is an important segment of the proposal.
描述:主要研究者陈述的重要性
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Bertram Oliver Fraser-Reid其他文献
Bertram Oliver Fraser-Reid的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Bertram Oliver Fraser-Reid', 18)}}的其他基金
Laboratory Syntheses of Mycobacterial tuberculosis LAM Prototypes
结核分枝杆菌 LAM 原型的实验室合成
- 批准号:
7626500 - 财政年份:2009
- 资助金额:
$ 16.02万 - 项目类别:
PENTENYL GLYCOSIDES--TRANSFORMATIONS AT ANOMERIC CENTER
戊烯基糖苷——异头中心的转化
- 批准号:
6093934 - 财政年份:1996
- 资助金额:
$ 16.02万 - 项目类别:
PENTENYL GLYCOSIDES--TRANSFORMATIONS AT ANOMERIC CENTER
戊烯基糖苷——异头中心的转化
- 批准号:
2180689 - 财政年份:1996
- 资助金额:
$ 16.02万 - 项目类别:
PENTENYL GLYCOSIDES--TRANSFORMATIONS AT ANOMERIC CENTER
戊烯基糖苷——异头中心的转化
- 批准号:
2770957 - 财政年份:1996
- 资助金额:
$ 16.02万 - 项目类别:
PENTENYL GLYCOSIDES IN TRANSFORMATIONS AT ANOMERIC CTR
异头 CTR 转化中的戊烯基糖苷
- 批准号:
3299121 - 财政年份:1990
- 资助金额:
$ 16.02万 - 项目类别:
相似海外基金
Bifunctional Catalysts for MHAT Hydrofunctionalization of Alkenes
用于烯烃 MHAT 加氢官能化的双功能催化剂
- 批准号:
2400341 - 财政年份:2024
- 资助金额:
$ 16.02万 - 项目类别:
Continuing Grant
Environmentally Benign Precise Transformations of Alkenes by Chiral Chalcogenide Catalysts
手性硫属化物催化剂对环境无害的烯烃精确转化
- 批准号:
22KJ2498 - 财政年份:2023
- 资助金额:
$ 16.02万 - 项目类别:
Grant-in-Aid for JSPS Fellows
electrochemical dication pool: a new strategy to couple alkenes and abundant nucleophiles
电化学双阳离子池:偶联烯烃和丰富亲核试剂的新策略
- 批准号:
10635132 - 财政年份:2023
- 资助金额:
$ 16.02万 - 项目类别:
Development of Remote Bismetalation Reaction of Alkenes via Chain Walking
链式行走烯烃远程双金属化反应的进展
- 批准号:
22KJ2699 - 财政年份:2023
- 资助金额:
$ 16.02万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Connective Stereospecific Generation of Alkenes Continued
烯烃的连接立体定向生成(续)
- 批准号:
2247031 - 财政年份:2023
- 资助金额:
$ 16.02万 - 项目类别:
Standard Grant
Expanding the small molecule toolbox through novel applications of fluorinated alkenes
通过氟化烯烃的新颖应用扩展小分子工具箱
- 批准号:
10714822 - 财政年份:2023
- 资助金额:
$ 16.02万 - 项目类别:
Methods for Enantioselective Spirocycle Synthesis and Radical Hydroamination of Trisubstituted Alkenes
三取代烯烃的对映选择性螺环合成和自由基氢胺化方法
- 批准号:
10785901 - 财政年份:2023
- 资助金额:
$ 16.02万 - 项目类别:
Ruthenium-catalyzed hydrophosphination of alkenes
钌催化的烯烃氢膦酸化
- 批准号:
575021-2022 - 财政年份:2022
- 资助金额:
$ 16.02万 - 项目类别:
University Undergraduate Student Research Awards
New Catalytic Transformations for the Synthesis of Alkenes and Organoboron Compounds
烯烃和有机硼化合物合成的新催化转化
- 批准号:
2102231 - 财政年份:2021
- 资助金额:
$ 16.02万 - 项目类别:
Continuing Grant
Development of Enantioselective Carboalumination of Alkenes and Alkynes Catalyzed by Rare-Erath Metal Catalysts
稀土金属催化剂催化烯烃和炔烃对映选择性碳铝化反应的研究进展
- 批准号:
21F21334 - 财政年份:2021
- 资助金额:
$ 16.02万 - 项目类别:
Grant-in-Aid for JSPS Fellows